Ionis Pharmaceuticals IONS Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's change in other liabilities?
- Ionis Pharmaceuticals (IONS) reported change in other liabilities of $21M in Q1 2026.
- How has Ionis Pharmaceuticals's change in other liabilities changed year-over-year?
- Ionis Pharmaceuticals's change in other liabilities increased by 6207.2% year-over-year, from $333K to $21M.
- What does change in other liabilities mean?
- The net change in miscellaneous short-term obligations not classified elsewhere.
- How do you interpret change in other liabilities?
- An increase provides a source of cash, while a decrease represents a cash outflow as obligations are settled.
- How does change in other liabilities compare across companies?
- Standard catch-all category; peers with complex revenue recognition or service contracts will often have significant activity here.